-
December 06, 2012
The pharmaceutical industry is slowly showing signs of recovery from one of the biggest patent cliffs in recent ...
-
December 06, 2012
The pharmaceutical industry is slowly showing signs of recovery from one of the biggest patent cliffs in recent ...
-
December 06, 2012
Tensions in the Middle East are really starting to ratchet higher. Egypt is seemingly descending into anarchy after ...
-
December 04, 2012
Teva Pharmaceutical Industries Ltd. (TEVA) recently provided guidance for 2013. The company expects to earn $4.85 ...
-
November 28, 2012
New York, May 10th (TradersHuddle.com) - Research Analyst's early calls ahead of the bell.
Prudential (NYSE:PRU) ...
-
November 27, 2012
Bayer (BAYRY) recently announced that it will not go ahead with its proposed acquisition of nutritional supplement ...
-
November 15, 2012
Forest Laboratories, Inc. (FRX) is taking steps to extend the lifecycle of its Alzheimer's disease product, Namenda ...
-
November 09, 2012
Jazz Pharmaceuticals plc (JAZZ) reported third quarter 2012 earnings (including share-based compensation charges but ...
-
November 07, 2012
Can Endo reestablish itself as a quality healthcare name?
-
November 06, 2012
Myriad Genetics (MYGN) reported earnings per share ('EPS') of 36 cents for the first quarter of fiscal 2013. The ...
-
November 05, 2012
Teva has restructuring and growth opportunities, but the risk is still elevated.
-
November 02, 2012
Teva Pharmaceutical Industries' (TEVA) third quarter earnings of $1.28 per American Depositary Share (ADS) were 3 ...
-
October 24, 2012
Eli Lilly & Company (LLY) reported third quarter 2012 adjusted earnings per share of 79 cents, missing the Zacks ...
-
October 23, 2012
Watson Pharmaceuticals, Inc. (WPI) recently announced that it has gained US Food and Drug Administration (FDA) ...
-
October 22, 2012
Jazz Pharmaceuticals plc (JAZZ) recently completed the sale of its women's health business to Meda Pharmaceuticals ...
-
October 16, 2012
The US Food and Drug Administration (FDA) recently extended the Prescription Drug User Fee Act (PDUFA) date for ...
-
October 11, 2012
The US Food and Drug Administration (FDA) recently approved Perrigo Company's (PRGO) Abbreviated New Drug ...
-
October 10, 2012
We are maintaining our Neutral recommendation on Mylan Inc. (MYL) with a target price of $26.00. The stock carries a ...
-
October 09, 2012
Watson Pharmaceuticals, Inc. (WPI) recently received the green signal from the European Commission (EC) for its ...
-
October 09, 2012
New York, May 23rd (TradersHuddle.com) - These are the research analyst new ratings before the market open. ...
